Migraine

Business of Healthcare | Finance

Theranica Secures $45 Million Series C Funding Round

Pharmacy

Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine

Devices | Pharmacy | Research

Study Compares Nerivio to Standard Care Medications for Acute Treatment of Migraine in Adolescents

Apps | Awards and Recognition | Devices

Nerivio Wins 2021 Medical Design Excellence Award

Devices

Nerivio Wearable Migraine Therapeutic Now Eligible for Coverage through UpScript’s Telemedicine Platform

Channel Marketing

Nerivio^® Drug-free Wearable Surpasses 100,000 Migraine Treatments in the US

Devices | Innovation & Technology

FDA Approves Theranica’s Nerivio^® for Acute Treatment of Migraine in Adolescents

Devices | Partnerships

U.S. Military Gains Quicker Access to Migraine Relief through FDA-Cleared CEFALY Technology